dsm-firmenich provides additional pro forma financial information for 2022 and 2023

KAISERAUGST, Switzerland and HEERLEN, Netherlands, Oct. 4, 2023 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, provides additional pro forma financial information for 2022 and 2023.

The historical pro forma financials are prepared as a combination of the historical figures reported by DSM N.V. and Firmenich SA.

The historical pro forma financials are unaudited and include estimates and approximations.

Methodology

The 2022 pro forma financials are prepared as a combination of the historical figures reported by DSM N.V. and Firmenich SA.
The 2022 pro forma financials are unaudited and include estimates, including for example approximations due to the different reporting currencies. The reporting currency of dsm-firmenich is EUR.
The following reporting perimeter changes and adjustments are applied:
- Changes to the Business Units' reporting perimeters: combination of the units T&B and F&B in TTH; Personal Care & Aroma (PCA) transfer to P&B from HNC; other minor adjustments including the Consumer Healthcare business transfer from T&B to HNC.
- Intercompany profit elimination: HNC net sales were reduced by approximately €50m to eliminate ingredient sales to Firmenich.

Further information for the basis of preparation of the pro forma financials and related definitions can be found in the H1 2023 results press release.

 

About dsm-firmenich 
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
www.dsm-firmenich.com 

For more information

Media
e-mail media@dsm-firmenich.com

Investors
e-mail investors@dsm-firmenich.com

Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.

Logo - https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/dsm-firmenich-provides-additional-pro-forma-financial-information-for-2022-and-2023-301946242.html